Condensed vs. Standard Step‐Up Dosing Schedule of Talquetamab in Relapsed/Refractory Multiple Myeloma
Grace Elsey, James A. Davis, Kelley Julian, Rebecca Gonzalez et autres
OBJECTIVE: To compare the incidence and severity of cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS) between two different step-up dosing (SUD) schedules with talquetamab, the standard SUD schedule of Days 1, 4, 7, and 10 and a condensed …
us (code pays fourni par la source)
0 citations
European Journal Of Haematology